MiR34 contributes to spinal muscular atrophy and AAV9-mediated delivery of MiR34a ameliorates the motor deficits in SMA mice-Reference-Cited by-同舟云学术

MiR34 contributes to spinal muscular atrophy and AAV9-mediated delivery of MiR34a ameliorates the motor deficits in SMA mice

Published:2023-06 Issue: Volume:32 Page:144-160
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Chen Tai-Heng,Chang Shih-Hsin,Wu Yu-Fu,Yen Ya-Ping,Hsu Fang-Yu,Chen Yen-Chung,Ming Yang,Hsu Ho-Chiang,Su Yi-Ching,Wong Sheng-Tang,Hung Jui-Hung,Chiou Shih-Hwa,Jong Yuh-Jyh,Chen Jun-An^ORCID

Funder

Ministry of Science and Technology

Taiwan Ministry of Science and Technology

National Health Research Institutes

Kaohsiung Medical University Chung Ho Memorial Hospital

National Science and Technology Council

Academia Sinica

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference89 articles.

1. Animal models of spinal muscular atrophy;Schmid;J. Child Neurol.,2007

2. SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens;Rochette;Hum. Genet.,2001

3. Spinal muscular atrophy;Lunn;Lancet,2008

4. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease;Monani;Neuron,2005

5. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?;Burghes;Nat. Rev. Neurosci.,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of MiRNA-34 family in different signaling pathways and its therapeutic options;Gene;2024-12

2. Insights into spinal muscular atrophy from molecular biomarkers;Neural Regeneration Research;2024-06-26

3. Revealing the potential role of hsa-miR-663a in modulating the PI3K-Akt signaling pathway via miRNA microarray in spinal muscular atrophy patient fibroblast-derived iPSCs;Journal of Neuropathology & Experimental Neurology;2024-06-18

4. Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era;Frontiers in Neurology;2023-11-13